| scholarly article | Q13442814 |
| P50 | author | Sébastien S. Hébert | Q42384154 |
| Peter T Nelson | Q90936675 | ||
| P2093 | author name string | Véronique Dorval | |
| P2860 | cites work | Tau promoter confers neuronal specificity and binds Sp1 and AP-2 | Q24290251 |
| Secretory mechanisms and intercellular transfer of microRNAs in living cells | Q24603413 | ||
| MicroRNA 802 stimulates ROMK channels by suppressing caveolin-1 | Q24630318 | ||
| A mammalian microRNA expression atlas based on small RNA library sequencing | Q24644709 | ||
| Widespread microRNA repression by Myc contributes to tumorigenesis | Q24647067 | ||
| MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders | Q24652987 | ||
| Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease | Q24678457 | ||
| A blood based 12-miRNA signature of Alzheimer disease patients | Q27499741 | ||
| MicroRNAs in the brain: it's regulatory role in neuroinflammation | Q38073708 | ||
| Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways | Q39975165 | ||
| A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene | Q39978280 | ||
| Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration | Q48112220 | ||
| Characterization of the 5'-end region and the first two exons of the beta-protein precursor gene | Q48303443 | ||
| An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. | Q48502415 | ||
| Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia | Q48550309 | ||
| Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. | Q48963534 | ||
| Tau immunoreactivity detected in human plasma, but no obvious increase in dementia. | Q53231337 | ||
| Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease. | Q53448282 | ||
| Regulation of microRNA biogenesis and function. | Q54531026 | ||
| Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease | Q57132920 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| The gamma-secretase complex: membrane-embedded proteolytic ensemble | Q28248433 | ||
| MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice | Q28287534 | ||
| A microRNA component of the p53 tumour suppressor network | Q28305330 | ||
| Gene network and pathway analysis of mice with conditional ablation of Dicer in post-mitotic neurons | Q28592712 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection | Q29618076 | ||
| The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor | Q29618322 | ||
| A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. | Q30539598 | ||
| Biomarkers in translational research of Alzheimer's disease | Q33556189 | ||
| Mechanisms of age-related cognitive change and targets for intervention: epigenetics. | Q33565018 | ||
| National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease | Q34635272 | ||
| MicroRNA isolation and stability in stored RNA samples | Q35004301 | ||
| MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease | Q35433358 | ||
| CSF biomarkers for Alzheimer's disease: current utility and potential future use. | Q35600993 | ||
| miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. | Q35649100 | ||
| Exosomal miRNAs: Biological Properties and Therapeutic Potential | Q35899396 | ||
| MicroRNAs and the regulation of cell death | Q35937321 | ||
| Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease | Q35991723 | ||
| MicroRNAs: a developing story | Q36083275 | ||
| Plasma microRNA biomarkers for detection of mild cognitive impairment | Q36380583 | ||
| microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF) | Q36499038 | ||
| Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature | Q36575903 | ||
| Imaging amyloid deposition in Lewy body diseases | Q37087766 | ||
| A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. | Q37122270 | ||
| microRNAs and the immune response | Q37178538 | ||
| Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship | Q37218110 | ||
| MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma | Q37669025 | ||
| Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment | Q37755075 | ||
| MicroRNAs in development and disease | Q37899669 | ||
| MicroRNAs in Alzheimer's disease | Q37979612 | ||
| Biomarkers in Alzheimer's disease: a review | Q38027541 | ||
| MicroRNAs and neurodegeneration: role and impact | Q38048423 | ||
| P2507 | corrigendum / erratum | Erratum: Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers | Q58553536 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| microRNA | Q310899 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 24 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Frontiers in Molecular Neuroscience | Q27721913 |
| P1476 | title | Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers | |
| P478 | volume | 6 |
| Q38481462 | Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease? |
| Q39293214 | CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study |
| Q28082378 | Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise |
| Q45325968 | Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases |
| Q33584750 | Comprehensive characterization of serum microRNA profile in response to the emerging avian influenza A (H7N9) virus infection in humans |
| Q40781085 | Deficits in the miRNA-34a-regulated endogenous TREM2 phagocytosis sensor-receptor in Alzheimer's disease (AD); an update |
| Q48916102 | Design and Fabrication a Gold Nanoparticle-DNA Based Nanobiosensor for Detection of microRNA Involved in Alzheimer's Disease. |
| Q64106495 | Early in life effects and heredity: reconciling neo-Darwinism with neo-Lamarckism under the banner of the inclusive evolutionary synthesis |
| Q37699995 | Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications |
| Q99548852 | Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease |
| Q26785375 | Gene expression parallels synaptic excitability and plasticity changes in Alzheimer's disease |
| Q36867569 | How to interpret epigenetic association studies: a guide for clinicians |
| Q36191373 | Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells |
| Q27027950 | Methodological challenges in utilizing miRNAs as circulating biomarkers |
| Q27321168 | MiR-299-5p regulates apoptosis through autophagy in neurons and ameliorates cognitive capacity in APPswe/PS1dE9 mice |
| Q34628003 | MicroRNA expression profiling in PBMCs: a potential diagnostic biomarker of chronic hepatitis C |
| Q34324544 | MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease |
| Q39215093 | MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease. |
| Q57129924 | MicroRNAs in depression and suicide: Recent insights and future perspectives |
| Q26770754 | Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation |
| Q33810656 | Novel roles of non-coding brain RNAs in health and disease. |
| Q33738059 | Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases |
| Q46830133 | Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations |
| Q92714073 | Risk Factors Associated with Mild Cognitive Impairment among Apparently Healthy People and the Role of MicroRNAs |
| Q53480784 | Role of EEG as biomarker in the early detection and classification of dementia. |
| Q60959868 | Temporal Integrative Analysis of mRNA and microRNAs Expression Profiles and Epigenetic Alterations in Female SAMP8, a Model of Age-Related Cognitive Decline |
| Q35076344 | The emerging role of microRNAs in Alzheimer's disease |
| Q34426210 | The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? |
| Q34168908 | Universal disease biomarker: can a fixed set of blood microRNAs diagnose multiple diseases? |
| Q48600153 | miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. |
| Q36584886 | microRNAs as Biomarker in Depression Pathogenesis |
| Q58553536 | Erratum: Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers | main subject | P921 |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.